Chemically programmable immunity

Details for Australian Patent Application No. 2005213962 (hide)

Owner Altermune, LLC

Inventors Mullis, Kary B.

Agent FB Rice

Pub. Number AU-B-2005213962

PCT Pub. Number WO2005/079423

Priority 10/754,456 09.01.04 US

Filing date 7 January 2005

Wipo publication date 1 September 2005

Acceptance publication date 5 November 2009

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/07 (2006.01) Medicinal preparations containing antigens or antibodies - Bacillus

A61K 39/385 (2006.01) Medicinal preparations containing antigens or antibodies - Haptens or antigens, bound to carriers

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/12 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from bacteria

Event Publications

17 August 2006 PCT application entered the National Phase

  PCT publication WO2005/079423 Priority application(s): WO2005/079423

16 October 2008 Assignment before Grant

  Mullis, Kary The application has been assigned to Altermune, LLC

5 November 2009 Application Accepted

  Published as AU-B-2005213962

4 March 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005213965-Gene disruptions, compositions and methods relating thereto

2005213943-Insecticide compositions